CRA has provided economic assessments of competition in connection with several mergers of clinical laboratories. CRA has analyzed the degree of competition from hospital and physician-owned labs, the nature of bidding for capitated lab arrangements with providers, and the extent to which a national market exists for contracts with health plans exists.
Aggregate royalty for cellular SEPs in recent court decisions
This academic paper, “Aggregate Royalty for Cellular SEPs in Recent Court Decisions,” published in GRUR Patent by CRA Competition experts Nadia Soboleva and...